We couldn’t avoid stepping out today and share with you the great views from our offices.
We would like to create awareness of rare diseases and the necessity of collaborating to improve the quality of life of those suffering them. We thank RareDiseaseDay® for spreading the word! #ShowYourRare
We announce funding for our breakthrough anti-microbial research program by the Netherlands NACTAR program from the Netherlands organization for Scientific Research (NWO). The project MDR-Phage brings together the expertise and resources from Synovo GmbH, Qualizyme Diagnostics, the University of Twente, and the University of Amsterdam. Within the project, we will test our anti-microbial library of compounds […]
Today we would like to highlight the hard work of our students and encourage them to keep on improving. We believe they are becoming amazing researchers. Special congratulations to Sabrina Zoeller on her recently finished Master thesis “Effect of modified p38 MAPK inhibitors in B16-F10 melanoma” and to Natasha Cloos, who recently submitted her Master thesis “Pharmacological Potential […]
We are at the J.P. Morgan HEALTHCARE CONFERENCE on January 8 – 11, 2018. Come and meet us! The Synovo T-shirt will be running in San Francisco! Good luck finding it!
We hope for better healthcare worldwide.
Congratulations to Timo Göhler and Anaïs Sabrié, winners of the Nikolauslauf half marathon in Tübingen. We were happy to see Timo Göhler wearing the Synovo T-shirt.
Meet us in Bio-Europe on 6-8 November 2017 in Berlin
Thanks to those who believe in us and let us participate in the development of their products by providing pharmacology services. We have just delivered the results from the pharmacology study service number 1000! THANK YOU
Synovo is at Bionnale 2017 on 16-17 May in Berlin. Come and meet us!